Study protocol for a randomised controlled trial assessing the clinical and cost-effectiveness of the Journeying through Dementia (JtD) intervention compared to usual care

WRIGHT, Jessica, FOSTER, Alexis, COOPER, Cindy, SPRANGE, Kirsty, WALTERS, Stephen, BERRY, Katherine, MONIZ-COOK, Esme, LOBAN, Amanda, YOUNG, Tracey Anne, CRAIG, Claire, DENING, Tom, LEE, Ellen, BERESFORD-DENT, Julie, THOMPSON, Benjamin John, YOUNG, Emma, THOMAS, Benjamin David and MOUNTAIN, Gail (2019). Study protocol for a randomised controlled trial assessing the clinical and cost-effectiveness of the Journeying through Dementia (JtD) intervention compared to usual care. BMJ Open, 9 (9), e029207.

[img]
Preview
PDF
Craig_Study_protocol_for_a_randomsed_controlled(VoR).pdf - Published Version
Creative Commons Attribution.

Download (564kB) | Preview
Official URL: https://bmjopen.bmj.com/content/9/9/e029207.info
Open Access URL: https://bmjopen.bmj.com/content/bmjopen/9/9/e02920... (Published)
Link to published version:: https://doi.org/10.1136/bmjopen-2019-029207

Abstract

Introduction Services are being encouraged to provide postdiagnostic treatment to those with dementia but the availability of evidence-based interventions following diagnosis has not kept pace with increase in demand. To address this need, the Journeying through Dementia (JtD) intervention was created. A randomised controlled trial (RCT), based on a pilot study, is in progress. Methods and analysis The RCT is a pragmatic, two-arm, parallel group trial designed to test the clinical and cost-effectiveness of JtD compared with usual care. Recruitment will be through NHS services, third sector organisations and Join Dementia Research. The sample size is 486 randomised (243 to usual care and 243 to the intervention usual care). Participants can choose to ask a friend or relative (supporter) to become involved in the study. The primary outcome measure for participants is Dementia-Related Quality of Life (DEMQOL), collected at baseline and at 8 months’ postrandomisation. Secondary outcome measures will be collected from participants and supporters at those visits. Participants will also be followed up at 12 months’ postrandomisation with a reduced set of measures. A process evaluation will be conducted through qualitative and fidelity substudies. Analyses will compare the two arms of the trial on an intention to treat as allocated basis. The primary analyses will compare the mean DEMQOL scores of the participants at 8 months between the two study arms. A cost-effectiveness analysis will consider the incremental cost per Quality Adjusted Life Years of the intervention compared with usual care. Qualitative and fidelity substudies will be analysed through framework analysis and fidelity assessment tools respectively. Ethics and dissemination REC and HRA approval were obtained. A Data Monitoring and Ethics Committee has been constituted. Dissemination will be via publications, conferences and social media. Intervention materials will be made open access. Trial registration number ISRCTN17993825.

Item Type: Article
Additional Information: ** From BMJ via Jisc Publications Router ** Licence for this article: https://creativecommons.org/licenses/by/4.0/ **Journal IDs: eissn 2044-6055 **Article IDs: publisher-id: bmjopen-2019-029207 **History: published_online 13-09-2019; published 09-2019; accepted 09-08-2019; submitted 18-01-2019
Uncontrolled Keywords: Geriatric medicine, 1506, 1698, Randomised controlled trial, dementia, research protocol, post diagnostic support, self-management, well-being
Identification Number: https://doi.org/10.1136/bmjopen-2019-029207
Page Range: e029207
SWORD Depositor: Helen Garner
Depositing User: Helen Garner
Date Deposited: 07 Oct 2019 11:00
Last Modified: 07 Oct 2019 11:00
URI: http://shura.shu.ac.uk/id/eprint/25162

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics